<DOC>
	<DOCNO>NCT02036008</DOCNO>
	<brief_summary>The purpose study determine Gadofosveset Trisodium ( Gdfos , Ablavar ) useful magnetic resonance imaging ( MRI ) contrast agent accurately diagnose liver metastasis compare standard agent gadobutrol ( EcGd , Gadovist ) .</brief_summary>
	<brief_title>Gadofosveset Trisodium ( Ablavar , Gdfos ) Distinguishing Hemangiomas Metastases : A Prospective Trial</brief_title>
	<detailed_description>The propose study single centre , prospective trial compare sensitivity specificity use Gadofosveset Trisodium ( Gdfos , Ablavar ) MRI contrast agent compare gadobutrol ( EcGd , Gadovist ) . The study population include cancer patient 's refer MRI study liver rule metastasis . Those meet inclusion/exclusion criterion routine ( clinical ) MRI liver EcGd . They also receive additional MRI Gdfos within 4 week original study . The patient data anonymized image read radiologist radiology resident comparison make diagnostic accuracy EcGd-enhanced study Gdfos-enhanced study .</detailed_description>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Neoplasms , Second Primary</mesh_term>
	<mesh_term>Hemangioma</mesh_term>
	<mesh_term>Liver Neoplasms</mesh_term>
	<mesh_term>Liver Extracts</mesh_term>
	<criteria>know cancer refer MRI liver rule metastases focal liver lesion age &gt; 18 yo contraindication MRI MR contrast agent pregnancy unable obtain sequence and/or acceptable quality imaging</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Liver metastasis</keyword>
	<keyword>MRI</keyword>
	<keyword>Contrast Agents</keyword>
</DOC>